Tomophase Corporation acquired by Winstar from China
BURLINGTON, MA – April 18, 2014 – Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced today that Guangdong Winstar Medical Science Company, a medical company from China, has acquired the whole company assets of Tomophase corporation. And the company name will change to Tomophase Incorporation instead of its former name Tomophase Corporation.
Dr. Peter Norris, founder and former president of Tomophase Corporation, is currently acting as the senior advisor of the new company. The main technical personnel of Tomophase Corp. will continue to work for the new company. The Company's business is expanding, especially in increasing the development and clinical data collection in Chinese market.
Guangdong Winstar Medical Science Company was founded in 2013. The company management team includes international entrepreneurs and technical experts, with extensive experience in management, marketing and medical technology. The company is aimed to become a global leading solutions provider for respiratory diseases.
Tomophase is a leader in developing bronchoscopic-based systems for interventional pulmonology. Offering significantly higher resolution than either CT scan or ultrasound, OCTIS provides real-time, high resolution, sub-surface tissue imaging of airways and lungs, to be followed by diagnostic and therapeutic applications. Our goal is to provide physicians with heretofore unobtainable airway microstructural images to improve the management and clinical outcome of pulmonary disease. The company has 15 patent and applications issued and pending. FDA 510(k) clearance for OCTIS was received and the CE Mark is expected in 2015. The U.S. commercial launch is underway and the EU rollout is proceeding. The company is currently raising investment capital to meet the increasing international demand for the OCT Imaging System. Examples of our tissueimaging results are available at www.tomophase.com.